Table of Contents

January/February 2025; Volume 79,Issue 1

  1. Schmucki, Matt

    1. Recommendations for Artificial Intelligence Application in Continued Process Verification: A Journey Toward the Challenges and Benefits of AI in the Biopharmaceutical Industry
      Mario Stassen, Catarina S. Leitão, Toni Manzano, Francisco Valero, Benjamin Stevens, Matt Schmucki, David Hubmayr, Ferran Mirabent Rubinat, Sandrine Dessoy and Antonio Moreira
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 68-87; DOI: https://doi.org/10.5731/pdajpst.2024.012950

  2. Stassen, Mario

    1. Recommendations for Artificial Intelligence Application in Continued Process Verification: A Journey Toward the Challenges and Benefits of AI in the Biopharmaceutical Industry
      Mario Stassen, Catarina S. Leitão, Toni Manzano, Francisco Valero, Benjamin Stevens, Matt Schmucki, David Hubmayr, Ferran Mirabent Rubinat, Sandrine Dessoy and Antonio Moreira
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 68-87; DOI: https://doi.org/10.5731/pdajpst.2024.012950

  3. Stevens, Benjamin

    1. Recommendations for Artificial Intelligence Application in Continued Process Verification: A Journey Toward the Challenges and Benefits of AI in the Biopharmaceutical Industry
      Mario Stassen, Catarina S. Leitão, Toni Manzano, Francisco Valero, Benjamin Stevens, Matt Schmucki, David Hubmayr, Ferran Mirabent Rubinat, Sandrine Dessoy and Antonio Moreira
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 68-87; DOI: https://doi.org/10.5731/pdajpst.2024.012950

  4. Valero, Francisco

    1. Recommendations for Artificial Intelligence Application in Continued Process Verification: A Journey Toward the Challenges and Benefits of AI in the Biopharmaceutical Industry
      Mario Stassen, Catarina S. Leitão, Toni Manzano, Francisco Valero, Benjamin Stevens, Matt Schmucki, David Hubmayr, Ferran Mirabent Rubinat, Sandrine Dessoy and Antonio Moreira
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 68-87; DOI: https://doi.org/10.5731/pdajpst.2024.012950

  5. Verdonck, Tim

    1. Understanding Alignment in the Execution of Extractable Screening Studies Between Laboratories: Results of the ELSIE Lab Practices Sub-Team Industry Surveys
      Steven A. Zdravkovic, Qiang Fu, Aaron Flick, Bhargava Jana, Elizabeth Looney, Samuel Kikandi, Tim Verdonck, Lee Nagao and Mary Kate Bielinski
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 4-27; DOI: https://doi.org/10.5731/pdajpst.2024.012964

  6. Waldron, Kelly

    1. A Risk Assessment and Risk-Based Approach Review of Pre-Use/Post-Sterilization Integrity Testing (PUPSIT)
      Kelly Waldron, Amanda McFarland, Hal Baseman and Maik Jornitz
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 88-97; DOI: https://doi.org/10.5731/pdajpst.2024-003038.1

  7. Zdravkovic, Steven A.

    1. Understanding Alignment in the Execution of Extractable Screening Studies Between Laboratories: Results of the ELSIE Lab Practices Sub-Team Industry Surveys
      Steven A. Zdravkovic, Qiang Fu, Aaron Flick, Bhargava Jana, Elizabeth Looney, Samuel Kikandi, Tim Verdonck, Lee Nagao and Mary Kate Bielinski
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 4-27; DOI: https://doi.org/10.5731/pdajpst.2024.012964

  8. Zerr, Andreas

    1. Definition of Particle Visibility Threshold in Parenteral Drug Products—Towards Standardization of Visual Inspection Operator Qualification
      Filip M. Fedorowicz, Andreas Zerr, Roman Mathaes, Matthias Eisele, Swen Maas and Atanas Koulov
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 28-58; DOI: https://doi.org/10.5731/pdajpst.2024.012994
« Previous (Pages : 1 2 3 4 ... 4)next »
Back to top

In This Issue